Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws

Journal of Oral and Maxillofacial Surgery

Volumn 60, Issue 10, 2002, Pages 1111-1113

  Chao, Chiao Kang ^a   Chang, Long Chang ^a   Liu, Shyun Yen ^a   Wang, Jaang Jiun ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BASIC FIBROBLAST GROWTH FACTOR; BISPHOSPHONIC ACID DERIVATIVE; INTERFERON; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; CELL MIGRATION; DRUG EFFICACY; ENUCLEATION; GIANT CELL TUMOR; HEMANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; JAW TUMOR; MYELOMA; NONHUMAN; NOTE; OSTEOCLAST; OSTEOLYSIS; TUMOR RECURRENCE;

EID: 0036789189     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1053/joms.2002.36063     Document Type: Article

References (22)

1. Ezekowitz RAB, Mulliken JB, Folkman J: Interferon alpha-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456, 1992 (Erratta appear in N Engl J Med 330:300, 1994 and N Engl J Med 333:595, 1995)
2. Mulliken JB, Boon LM, Takahashi K, et al: Pharmacologic therapy for endangering hemangiomas. Curr Opin Dermatol 2:109, 1995
3. White CW, Sondheimer HM, Crouch EC, et al: Treatment of pulmonary hemangiomatosis with recombinant interferon alpha-2a. N Engl J Med 320:1197, 1989
4. Folkman J: Successful treatment of an angiogenic disease. N Engl J Med 320:1211, 1989
5. Brouty-Boye D, Zetter B: Inhibition of cell motility by interferon. Science 208:516, 1980
6. Dvorak HF, Gresser I: Microvascular injury in the pathogenesis of interferon induced necrosis of subcutaneous tumors in mice. J Natl Cancer Inst 81:497, 1989
7. Sidky YA, Borden EC: Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular diseases. Cancer Res 47:5155, 1987
8. Bielenberg DR, Bucana CD, Sanchez R, et al: Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 14:401, 1999
9. Folkman J, Mulliken JB, Ezekowitz RAB: Antiangiogenic therapy of hemangiomas with interferon alpha, in Stuart-Harris R, Penny R (eds): Clinical Applications of the Interferons. London, England, Chapman & Hall, 1997, pp 255-265
10. Singh RK, Fidler IJ: Systemic administration of interferons for inhibition of cancer metastasis, in Stuart-Harris R, Penny R (eds): Clinical Applications of the Interferons. London, England, Chapman & Hall, 1997, pp 391-404
11. Takayanagi H, Kim S, Matsuo K, et al: RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416:744, 2002
12. Lammert E, Cleaver O, Melton D: Induction of pancreatic differentiation by signals from blood vessels. Science 294:564, 2002
13. Rupnick MA, Panigrahy D, Zhang C-Y, et al: Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 99:10730, 2002
14. Terpos E, Palermos J, Viniou N, et al: Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment. Calcif Tissue Int 68:285, 2001
15. Slaton JW, Perrotte P, Inoue K, et al: Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. Clin Cancer Res 5:2726, 1999
16. 1 on in vitro angiogenesis. Exp Cell Res 204:356, 1993
17. Kaban LB, Mulliken JB, Ezekowitz RAB, et al: Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alpha-2a. Pediatrics 103:1145, 1999
18. Marler JL, Rubin JB, Trede NS, et al: Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: Report of 2 cases. Pediatrics 109:1, 2002
19. Nilsson A, Janson ET, Eriksson B, et al: Levels of angiogenic peptides in sera from patients with carcinoid tumours during alpha-interferon treatment. Anticancer Res 21:4087, 2001
20. Pinedo HM, Verheul HMW, D'Amato RJ, et al: Involvement of platelets in tumour angiogenesis? Lancet 352:1775, 1998
21. Relf M, LeJeune S, Scott PAE, et al: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57:963, 1997
22. Strander H: Toxicities of interferons, in Stuart-Harris R, Penny R (eds): Clinical Applications of the Interferons. London, England, Chapman & Hall, 1997, pp 331-363